However, PA manifesting parafibromin heterogeneity also had significantly lower proliferation activity than carcinomas, namely 2.2 % (95 % CI = 0.6–3.8) vs 10.6 % (95 % CI = 4.0–17.1) considering the larger cohort. The gene discussed is CDC73; the disease is carcinoma.